The New York-based firm, founded in 2014 as Canepa Healthcare and now known as Evidity Health Capital, specializes in investing in late-stage ventures and growth equity for companies with commercialized products that require funding to achieve profitability. Its focus is on the medical devices, in vitro diagnostics, and digital health sectors.